Archive

Volume 3, Number 2 / April issue 2017
Mohammad Gamal Mohammad, Khaled El Khashab, Hany Younan Azer Girgis, Hassan Mohammed Ebied, Ghada Mohamed Ezzat Ahmed
Correlation between glycosylated HbA1c level and severity of coronary atherosclerosis in non-diabetics
Abstract

Background: Glycosylated hemoglobin A1C (HbA1c) has been widely recognized as a marker for predicting the severity of diabetes mellitus (DM) and several cardiovascular diseases. However, whether HbA1c could predict presence and severity of coronary artery stenosis in non diabetic patients remains largely unknown. Aim of the work: To study glycosylated hemoglobin level (HbA1c) as an index of presence and severity of coronary artery disease in non-diabetic patients. Methods: We enrolled 100 non diabetic patients underwent coronary angiography for evaluation of chest pain. Patients were included if they had no history of prior revascularization or diabetes mellitus and had fasting blood glucose < 126 mg/dl (7.0 mmol/l) and HbA1c < 6.5% (47mmol/mol). The severity of the CAD was also evaluated using the Gensini score. Serum HbA1c, lipid profile, resting ECG, Echo Doppler and HOLTER monitoring were measured. The patients were classified into two groups by tertiles of baseline HbA1c level (low group (nondiabetics) <5.7%, n = 55; high group (prediabetics) between 5.7 and 6.3%, n = 45). The relationships between the plasma HbA1c and presence and severity of CAD and early clinical outcomes were evaluated. Results: There were a statistically significant correlation between the level of plasma HbA1C and angiographic characteristics (P <0.001), statistically significant correlation between the level of plasma HbA1C and total silent ischemic episodes detected by Holter monitoring (P =0.04) and statistically insignificant correlation between the level of plasma HbA1C and myocardial systolic function measured by EF % (P =0.5) Conclusion: High. HbA1C level was an independent predictor of the presence of CAD after adjusting for conventional risk factors of CAD (AUC = 0.8).
Keywords: HbAIc, coronary stenosis, non-diabetic

Cite this article:
Mohammad Gamal Mohammad, Khaled El Khashab, Hany Younan Azer Girgis, Hassan Mohammed Ebied, Ghada Mohamed Ezzat Ahmed. Correlation between glycosylated HbA1c level and severity of coronary atherosclerosis in non-diabetics. Acta Scientiae et Intellectus, 3(2)2017, 73-82.


REFERENCES

  1. Valentin Fuster, Richard A. Walsh, Robert A. O'Rourke, Philip Poole-Wilson Associate Editors: Spencer B. King III, Ira S. Nash, Robert Roberts, Eric N. Prystowsky, (2008), HURST’S the heart 12 edition.
  2. Eric J Topol, (2007), Textbook of Cardiovascular Medicine, 3rd Edition.
  3. Libby P., (2000), Changing concepts of atherogenesis. J Intern Med; 247: 349-358.
  4. Selvin E, Marinopoulos S, Berkenblit G et al., (2004), Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med; 141: 421-431.
  5. Stamler J, Vaccaro O, Neaton JD, Wentworth D. (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care; 16:434-44.
  6. Sullivan RD, Marwick HT, Ben FS. (1990) A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis with major risk factors. American Heart Journal; 119(6): 1262-7.
  7. Li-Feng Hong1,2, Xiao-Lin Li1, Yuan-Lin Guo1, Song-Hui Luo2, Cheng-Gang Zhu1, Ping Qing1, Rui-Xia Xu1, Na-Qiong Wu1 and Jian-Jun Li. (2014) Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina. Lipids in Health and Disease, 13:89.
  8. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25.
  9. Nichols M, Townsend N, Scarborough P, Rayner M. (2014) cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J; 35:2950.
  10. Ahmet Göktuğ Ertem, M.D., Hüseyin Bağbancı, M.D., Harun Kılıç, M.D., Ekrem Yeter, M.D., Ramazan Akdemir, M.D., (2013) Relationship between HbA1c levels and coronary artery severity in nondiabetic acute coronary syndrome patients, Arch Turk Soc Cardiol; 41(5): 389-395.
  11. Haleh Ashraf, Mohammad Ali Boroumand, Alireza Amirzadegan, Shaghayegh Ashraf Talesh, Gholamreza Davoodi. (2013) Hemoglobin A1C in non-diabetic patients: An independent predictor of coronary artery disease and its severity. Diabetes research and clinical practice; 102 (3): 225-232.
  12. Li-Feng Hong, Xiao-Lin Li1, Yuan-Lin Guo, Song-Hui Luo, Cheng-Gang Zhu, Ping Qing, Rui-Xia Xu, Na-Qiong Wu and Jian-Jun Li. (2014) Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina. Lipids in Health and Disease; 13:89-98.